Arcadia Biosciences, Inc. — Director's Dealing 2019

Jun 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2019-06-03

Reporting Person: Reiter Sarah (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-03	Stock Option (right to buy)	$5.04	A	23305	Acquired	2029-06-03	Common Stock (23305)	Direct

Footnotes

F1: The Option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or June 3, 2020, with the remaining 75% vesting in 36 equal installments beginning June 30, 2020 and ending May 31, 2023, subject to the Participant's continued service.